MAY 22·StockStory▲
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
The article reviews the Q1 earnings of research tools & consumables stocks, highlighting mixed results across the sector. Danaher (NYSE:DHR) reported revenues slightly below expectations, leading to an 11.4% stock decline. In contrast, Waters Corporation (NYSE:WAT) significantly outperformed, while Revvity (NYSE:RVTY), Thermo Fisher (NYSE:TMO), and Avantor (NYSE:AVTR) also presented varying financial outcomes and market reactions.
MAY 22·AD HOC NEWS→
Danaher Corp. stock (US2358511028): earnings beat keeps focus on life sciences recovery
Danaher Corp. reported a first-quarter 2026 earnings beat, exceeding Wall Street expectations, though revenue growth remained modest. The company's performance keeps investor attention on the recovery pace of its life sciences and diagnostics segments, which are crucial for its long-term growth. Danaher's diversified portfolio and strategic management system position it to capitalize on healthcare and scientific research trends, but near-term share price volatility reflects ongoing market sentiment concerns about demand in key end markets.
